Live feed07:00:00·101dPRReleaseRelmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for Two Separate IndicationsRLMD· Relmada Therapeutics Inc.Health CareOriginal source
